Christian Elze

“China’s policy makers are making a concerted long-term effort to build a competitive biomedical innovation system – but R&D-based value creation
is only just beginning.”

Christian Elze Senior Partner
Jan-Philipp Kruse

“Will the classic, opportunistic BD&L approach suffice to satisfy licensing and partnering demands in the 21st century?”

Graham Scholefield

“How can our clients develop an effective strategy which accounts for the rapidly changing drug reimbursement landscape?”

Flavia Botschen

“Are you open to innovation?”

Flavia Botschen Associate
Sophie von Dyrander

“My decision to join Catenion? Here I found what I was looking for – high level strategy work, international clients and the team spirit of a smaller firm.”

Markus Thunecke

“How can you grow an organization while maintaining its creative spark?”

Dr. Markus Thunecke Senior Partner
Matthias Krings

“Today, developing and launching a medical device needs know-how from classical drug development”

Dr. Matthias Krings Senior Partner


Value-Based Pharma R&D Productivity: Is There A Scalable Model?

IN VIVO, October 2014 The superior R&D and growth performance of companies like Celgene, Gilead, or Biogen can be attributed to a number of factors such as the size of the R&D budget, a high degree of portfolio focus, a good mixture of internal and external innovation sourcing, but most importantly a strong culture, leadership, and the ability to [...]
Download this article

Value-Based Pharma R&D Productivity: Is There A Sweet Spot?

IN VIVO, June 2014 What do Gilead, Biogen, and Celgene have in common? Qualities to be the top three drugmakers ranked by both R&D productivity and growth, according to a novel method for measuring such criteria that management consulting firm Catenion says offers insights for achieving such success.
Download this article

Meet Us

February 18-20, 2015

Opal Medical Devices Summit 2015, Bosten, MA

March 5th & 6st, 2015

Pharma PPM Toolbox – Basel

November 11th, 2015

Kyoto University, Lecture on „Healthcare Systems: Dynamics and Reform“ & Seminar on “ Development of a Global Clinical Trial Strategy for Lupus”